Skip to main content

What the FDA labels say about taking them together

Fluvastatin and letermovir

Letermovir's FDA label of January 14, 2026 names fluvastatin in its drug interactions section; the fluvastatin labels PlainMeds reads (2) do not name letermovir. The letermovir label: “When PREVYMIS is co-administered with these statins, a statin dosage reduction may be necessary. Closely monitor patients for myopathy and rhabdomyolysis. …”

Check it at the source: the fluvastatin FDA label on DailyMed (effective April 21, 2025, Teva Pharmaceuticals USA, Inc.); the letermovir FDA label on DailyMed (effective January 14, 2026, Merck Sharp & Dohme LLC).

What does the fluvastatin label say about letermovir?

Fluvastatin's label (effective April 21, 2025) and its 1 other brand-application label do not name letermovir in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Fluvastatin), Teva Pharmaceuticals USA, Inc., effective April 21, 2025 (SPL set aad8b373-0aec-4efb-8e61-3d8114b31127), via openFDA; the full label on DailyMed

What does the letermovir label say about fluvastatin?

Letermovir label, drug interactions

Concomitant Drug Class and/or Clearance Pathway/Drug Name: fluvastatin, lovastatin, pravastatin, rosuvastatin; Effect on Concentration ↓ =decrease, ↑ =increase: ↑ HMG-CoA reductase inhibitors; Clinical Comments: When PREVYMIS is co-administered with these statins, a statin dosage reduction may be necessary. Closely monitor patients for myopathy and rhabdomyolysis. When PREVYMIS is co-administered with cyclosporine, use of lovastatin is not recommended. When PREVYMIS is co-administered with cyclosporine, refer to the statin prescribing information for specific statin dosing recommendations.

Source: FDA drug label (PREVYMIS), Merck Sharp & Dohme LLC, effective January 14, 2026 (SPL set 1b49df80-be4f-47e0-a0b7-123f3e69395b), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

4Fluvastatin generic labelers
0Letermovir generic labelers
FluvastatinLetermovir
Labeled forHigh cholesteroln/a
Boxed warningNoNo
Pharmacy cost (NADAC)$2.88 per tablet 80 mg tabletn/a
Shortage nowA presentation being discontinuedNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?